Clinical trials of losartan - TrialResults-center.org

Losartan Monopotassium Salt - Losartan Potassium - DuP753 - DuP 753 - DuP-753 - MK954 - MK 954 - MK-954 - Cozaar - Losartan

Trial	Studied trt	Control trt	ROB	Trial result	Adverse events
Group by... in first in second in third	Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation			Global trial result Main results All results All result tag NCT results	Numeric bar chart forest plot medians
acute myocardial infarction
OPTIMAAL, 2002	Losartan	Captopril	Low risk of bias	suggesting
atrial fibrillation
LIFE (AF ancillary study), 2005	losartan	atenolol		suggesting
diabetes type 2
RENAAL, 2001	losartan	placebo	Low risk of bias	suggesting
LIFE (diabetic subgroup), 2002	losartan	atenolol	Low risk of bias	suggesting
diabetic kidney disease
RENAAL, 2001	losartan	placebo	Low risk of bias	suggesting
heart failure
HEAAL, 2009 NCT	losartan 150mg	losartan 50mg	Low risk of bias	suggesting
Losartan Phase III International, 1996	losartan	placebo	Low risk of bias	suggesting
Losartan Phase III U.S., 1995	losartan	placebo	Low risk of bias	negative
Hamroff et al., 1999	losartan+ACE inhibitor	ACE inhibitor only	Low risk of bias	-
ELITE, 1997	losartan	captopril	Low risk of bias	negative
ELITE II, 2000	losartan	captopril	Low risk of bias	-
Dickstein et al., 1995	losartan	enalapril	Low risk of bias	-
Lang et al., 1997	losartan	enalapril	Low risk of bias	-
Losartan phase II S, 1996	losartan	enalapril	Low risk of bias	-
losartan phase II US, 1996	losartan	enalapril	Low risk of bias	-
hypertension
RENAAL, 2001	losartan	placebo	Low risk of bias	suggesting
RENAAL, 2001	losartan	placebo	Low risk of bias	-
LIFE, 2002	losartan	atenolol	Low risk of bias	suggesting
LIFE (diabetic subgroup), 2002	losartan	atenolol	Low risk of bias	suggesting
ELITE, 1997	Losartan	Captopril	Low risk of bias	suggesting
ELITE-II, 2000	Losartan	Captopril	Low risk of bias	negative
OPTIMAAL, 2001	Losartan	Captopril	Risk of bias	negative
miscellaneous
RENAAL, 2001	losartan	placebo	Low risk of bias	-
LIFE, 2002	losartan	atenolol	Low risk of bias	suggesting
patients at high risk for cardiovascular events
RENAAL, 2001	losartan	placebo	Low risk of bias	-
LIFE, 2002	losartan	atenolol	Low risk of bias	suggesting

Losartan angiotensin-receptor blockers systematic review meta-analysis network meta-analysis

Group by...

Losartan angiotensin-receptor blockers
systematic review meta-analysis network meta-analysis